Literature DB >> 34177007

Learning Optimal Distributionally Robust Individualized Treatment Rules.

Weibin Mo1, Zhengling Qi2, Yufeng Liu3.   

Abstract

Recent development in the data-driven decision science has seen great advances in individualized decision making. Given data with individual covariates, treatment assignments and outcomes, policy makers best individualized treatment rule (ITR) that maximizes the expected outcome, known as the value function. Many existing methods assume that the training and testing distributions are the same. However, the estimated optimal ITR may have poor generalizability when the training and testing distributions are not identical. In this paper, we consider the problem of finding an optimal ITR from a restricted ITR class where there is some unknown covariate changes between the training and testing distributions. We propose a novel distributionally robust ITR (DR-ITR) framework that maximizes the worst-case value function across the values under a set of underlying distributions that are "close" to the training distribution. The resulting DR-ITR can guarantee the performance among all such distributions reasonably well. We further propose a calibrating procedure that tunes the DR-ITR adaptively to a small amount of calibration data from a target population. In this way, the calibrated DR-ITR can be shown to enjoy better generalizability than the standard ITR based on our numerical studies.

Entities:  

Keywords:  Covariate shifts; Distributionally robust optimization; Generalizability; Individualized treatment rules

Year:  2020        PMID: 34177007      PMCID: PMC8221611          DOI: 10.1080/01621459.2020.1796359

Source DB:  PubMed          Journal:  J Am Stat Assoc        ISSN: 0162-1459            Impact factor:   5.033


  20 in total

Review 1.  The Women's Interagency HIV Study: an observational cohort brings clinical sciences to the bench.

Authors:  Melanie C Bacon; Viktor von Wyl; Christine Alden; Gerald Sharp; Esther Robison; Nancy Hessol; Stephen Gange; Yvonne Barranday; Susan Holman; Kathleen Weber; Mary A Young
Journal:  Clin Diagn Lab Immunol       Date:  2005-09

2.  The use of propensity scores to assess the generalizability of results from randomized trials.

Authors:  Elizabeth A Stuart; Stephen R Cole; Catherine P Bradshaw; Philip J Leaf
Journal:  J R Stat Soc Ser A Stat Soc       Date:  2001-04-01       Impact factor: 2.483

3.  Robustifying Trial-Derived Optimal Treatment Rules for A Target Population.

Authors:  Ying-Qi Zhao; Donglin Zeng; Catherine M Tangen; Michael L LeBlanc
Journal:  Electron J Stat       Date:  2019-04-30       Impact factor: 1.125

4.  A general statistical framework for subgroup identification and comparative treatment scoring.

Authors:  Shuai Chen; Lu Tian; Tianxi Cai; Menggang Yu
Journal:  Biometrics       Date:  2017-02-17       Impact factor: 2.571

5.  Residual Weighted Learning for Estimating Individualized Treatment Rules.

Authors:  Xin Zhou; Nicole Mayer-Hamblett; Umer Khan; Michael R Kosorok
Journal:  J Am Stat Assoc       Date:  2017-05-03       Impact factor: 5.033

6.  Multicategory Outcome Weighted Margin-based Learning for Estimating Individualized Treatment Rules.

Authors:  Chong Zhang; Jingxiang Chen; Haoda Fu; Xuanyao He; Ying-Qi Zhao; Yufeng Liu
Journal:  Stat Sin       Date:  2020       Impact factor: 1.261

7.  Eligibility criteria for HIV clinical trials and generalizability of results: the gap between published reports and study protocols.

Authors:  Monica Gandhi; Niloufar Ameli; Peter Bacchetti; Gerald B Sharp; Audrey L French; Mary Young; Stephen J Gange; Kathryn Anastos; Susan Holman; Alexandra Levine; Ruth M Greenblatt
Journal:  AIDS       Date:  2005-11-04       Impact factor: 4.177

8.  A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter. AIDS Clinical Trials Group Study 175 Study Team.

Authors:  S M Hammer; D A Katzenstein; M D Hughes; H Gundacker; R T Schooley; R H Haubrich; W K Henry; M M Lederman; J P Phair; M Niu; M S Hirsch; T C Merigan
Journal:  N Engl J Med       Date:  1996-10-10       Impact factor: 91.245

9.  Estimating Optimal Treatment Regimes from a Classification Perspective.

Authors:  Baqun Zhang; Anastasios A Tsiatis; Marie Davidian; Min Zhang; Eric Laber
Journal:  Stat       Date:  2012-01-01

10.  Generalizing Evidence from Randomized Trials using Inverse Probability of Sampling Weights.

Authors:  Ashley L Buchanan; Michael G Hudgens; Stephen R Cole; Katie R Mollan; Paul E Sax; Eric S Daar; Adaora A Adimora; Joseph J Eron; Michael J Mugavero
Journal:  J R Stat Soc Ser A Stat Soc       Date:  2018-02-26       Impact factor: 2.483

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.